Erratum: Fibromodulin-deficiency alters temporospatial expression patterns of transforming growth factor-β ligands and receptors during adult mouse skin wound healing (PLoS ONE (2014) 9:3 (e90817) DOI: 10.1371/journal.pone.0090817);Fibromodulin-deficiency alters temporospatial expression patterns of transforming growth factor-β ligands and receptors during adult mouse skin wound healing

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Zheng, Zhong ^a   Lee, Kevin S ^a   Zhang, Xinli ^a   Nguyen, Calvin ^a   Hsu, Chingyun ^a   Wang, Joyce Z ^b   Rackohn, Todd Matthew ^a   Enjamuri, Dwarak Reddy ^a   Murphy, Maxwell ^a   Ting, Kang ^a   Soo, Chia ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SUNY DOWNSTATE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROMODULIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA3;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOLOGICAL ACTIVITY; CELL INFILTRATION; CELL MIGRATION; CELL PROLIFERATION; COLLAGEN SYNTHESIS; CONTROLLED STUDY; EPITHELIUM CELL; GRANULATION TISSUE; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; INFLAMMATORY CELL; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCAR FORMATION; SKIN CELL; TISSUE LEVEL; TISSUE REGENERATION; TISSUE STRUCTURE; WOUND CLOSURE; WOUND HEALING;

EID: 84897147185     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0246557     Document Type: Erratum

References (86)

1. Clark R (1996) Wound repair: overview and general considerations In: Clark R, editor. The Molecular and Cellular Biology of Wound Repair. New York: Plenum Press. pp. 3-50.
2. Broughton G Jr, Janis JE, Attinger CE (2006) The basic science of wound healing. Plast Reconstr Surg 117: 12S-34S. (Pubitemid 44317769)
3. Lorenz HP, Longaker MT (2008) Wounds: Biology, Pathology, and Management. In: Norton JA, Barie PS, Bollinger RR, Chang AE, Lowry SF et al., editors. Surgery: Springer New York.
4. Clark RAF, Henson PM (1988) The molecular and cellular biology of wound repair. New York: Plenum Press.
5. O'Kane S, Ferguson MW (1997) Transforming growth factor bs and wound healing. International Journal of Biochemistry and Cell Biology 29: 63-78. (Pubitemid 27096420)
6. Henry G, Garner WL (2003) Inflammatory mediators in wound healing. Surg Clin North Am 83: 483-507. (Pubitemid 36687709)
7. Singer AJ, Clark RA (1999) Cutaneous wound healing. N Engl J Med 341: 738-746. (Pubitemid 29407375)
8. Massague J (1990) The transforming growth factor-beta family. Annu Rev Cell Biol 6: 597-641.
9. Penn JW, Grobbelaar AO, Rolfe KJ (2012) The role of the TGF-beta family in wound healing, burns and scarring: a review. Int J Burns Trauma 2: 18-28.
10. Chaudhury A, Howe PH (2009) The Tale of Transforming Growth Factor-Beta (TGF beta) Signaling: A Soigne Enigma. Iubmb Life 61: 929-939.
11. Graycar JL, Miller DA, Arrick BA, Lyons RM, Moses HL, et al. (1989) Human transforming growth factor-beta 3: recombinant expression, purification, and biological activities in comparison with transforming growth factors-beta 1 and - beta 2. Mol Endocrinol 3: 1977-1986. (Pubitemid 20036903)
12. Bandyopadhyay B, Fan J, Guan S, Li Y, Chen M, et al. (2006) A "traffic control" role for TGFβ3: orchestrating dermal and epidermal cell motility during wound healing. The Journal of Cell Biology 172: 1093-1105.
13. Han GW, Li FL, Singh TP, Wolf P, Wang XJ (2012) The Pro-inflammatory Role of TGF beta 1: A Paradox? International Journal Of Biological Sciences 8: 228-235.
14. Zheng Z, Nguyen C, Zhang XL, Khorasani H, Wang JZ, et al. (2011) Delayed Wound Closure in Fibromodulin-Deficient Mice Is Associated with Increased TGF-beta 3 Signaling. Journal of Investigative Dermatology 131: 769-778.
15. Shah M, Foreman DM, Ferguson MW (1995) Neutralisation of TGF-beta 1 and TGF-beta 2 or exogenous addition of TGF-beta 3 to cutaneous rat wounds reduces scarring. J Cell Sci 108: 985-1002.
16. Lin RY, Sullivan KM, Argenta PA, Meuli M, Lorenz HP, et al. (1995) Exogenous transforming growth factor-beta amplifies its own expression and induces scar formation in a model of human fetal skin repair. Annals of Surgery 222: 146-154.
17. Wu LC, Siddiqui A, Morris DE, Cox DA, Roth SI, et al. (1997) Transforming growth factor beta 3 (TGF beta 3) accelerates wound healing without alteration of scar prominence - Histologic and competitive reverse-transcription polymerase chain reaction studies. Archives of Surgery 132: 753-760. (Pubitemid 27305229)
18. Murata H, Zhou L, Ochoa S, Hasan A, Badiavas E, et al. (1997) TGF-beta 3 stimulates and regulates collagen synthesis through TGF-beta 1-dependent and independent. Journal of Investigative Dermatology 108: 258-262. (Pubitemid 27116220)
19. Occleston NL, Laverty HG, O'Kane S, Ferguson MW (2008) Prevention and reduction of scarring in the skin by Transforming Growth Factor beta 3 (TGFbeta3): from laboratory discovery to clinical pharmaceutical. J Biomater Sci Polym Ed 19: 1047-1063. (Pubitemid 351957390)
20. (2011) Juvista Fails Late-Stage Trial. Drug. Discovery & Development (www.ddmag.com).
21. Danielpour D, Sporn MB (1990) Differential inhibition of transforming growth factor beta 1 and beta 2 activity by alpha 2-macroglobulin. J Biol Chem 265: 6973-6977.
22. Paralkar VM, Vukicevic S, Reddi AH (1991) Transforming Growth-Factor-Beta Type-1 Binds to Collagen-Iv of Basement-Membrane Matrix - Implications for Development. Developmental Biology 143: 303-308. (Pubitemid 121004656)
23. Hildebrand A, Romaris M, Rasmussen L, Heinegard D, Twardzik D, et al. (1994) Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor b. Biochem J 302: 527-534. (Pubitemid 24280108)
24. Grande J, Melder D, Zinsmeister A, Killen P (1993) Transforming growth factor-beta 1 induces collagen IV gene expression in NIH-3T3 cells. Lab Invest 69: 387-395.
25. Li X, McFarland DC, Velleman SG (2006) Effect of transforming growth factor-beta on decorin and beta1 integrin expression during muscle development in chickens. Poult Sci 85: 326-332. (Pubitemid 44509928)
26. Heegaard AM, Xie ZJ, Young MF, Nielsen KL (2004) Transforming growth factor beta stimulation of biglycan gene expression is potentially mediated by Sp1 binding factors. J Cell Biochem 93: 463-475. (Pubitemid 44264182)
27. Kolb M, Margetts PJ, Sime PJ, Gauldie J (2001) Proteoglycans decorin and biglycan differentially modulate TGF-beta-mediated fibrotic responses in the lung. American Journal of Physiology-Lung Cellular and Molecular Physiology 280: L1327-L1334.
28. Zhang Z, Garron TM, Li XJ, Liu Y, Zhang X, et al. (2009) Recombinant human decorin inhibits TGF-beta1-induced contraction of collagen lattice by hypertrophic scar fibroblasts. Burns 35: 527-537.
29. Zhang Z, Li XJ, Liu Y, Zhang X, Li YY, et al. (2007) Recombinant human decorin inhibits cell proliferation and downregulates TGF-beta1 production in hypertrophic scar fibroblasts. Burns 33: 634-641. (Pubitemid 46880036)
30. Isaka Y, Brees DK, Ikegaya K, Kaneda Y, Imai E, et al. (1996) Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney. Nat Med 2: 418-423. (Pubitemid 26191913)
31. Baghy K, Iozzo RV, Kovalszky I (2012) Decorin-TGF beta Axis in Hepatic Fibrosis and Cirrhosis. Journal of Histochemistry & Cytochemistry 60: 262-268.
32. Iozzo RV, Goldoni S, Berendsen AD, Young MF (2011) Small Leucine-Rich Proteoglycans: The Extracellular Matrix: an Overview. In: Mecham RP, editor: Springer Berlin Heidelberg. pp. 197-231.
33. Merline R, Schaefer RM, Schaefer L (2009) The matricellular functions of small leucine-rich proteoglycans (SLRPs). J Cell Commun Signal 3: 323-335.
34. Schaefer L, Schaefer RM (2010) Proteoglycans: from structural compounds to signaling molecules. Cell Tissue Res 339: 237-246.
35. Bi Y, Ehirchiou D, Kilts TM, Inkson CA, Embree MC, et al. (2007) Identification of tendon stem/progenitor cells and the role of the extracellular matrix in their niche. Nat Med 13: 1219-1227. (Pubitemid 47530625)
36. Svensson L, Aszodi A, Reinholt F, Heinegard D, Oldberg A (1999) Fibromodulin-null mice have abnormal collagen fibrils, tissue organization, and altered lumican deposition in tendon. J Biol Chem 274: 9636-9647.
37. Viola M, Bartolini B, Sonaggere M, Giudici C, Tenni R, et al. (2007) Fibromodulin interactions with type I and II collagens. Connect Tissue Res 48: 141-148. (Pubitemid 46860601)
38. Zheng Z, Jian J, Zhang XL, Zara JN, Yin W, et al. (2012) Reprogramming of human fibroblasts into multipotent cells with a single ECM proteoglycan, fibromodulin. Biomaterials 33: 5821-5831.
39. Iozzo RV, Schaefer L (2010) Proteoglycans in health and disease: novel regulatory signaling mechanisms evoked by the small leucine-rich proteoglycans. Febs Journal 277: 3864-3875.
40. Soo C, Beanes S, Dang C, Zhang X, Ting K (2001) Fibromodulin, a TGF-β modulator, promotes scarless fetal repair. Surgical Forum 578-581.
41. Soo C, Hu FY, Zhang X, Wang Y, Beanes SR, et al. (2000) Differential expression of fibromodulin, a transforming growth factor-beta modulator, in fetal skin development and scarless repair. Am J Pathol 157: 423-433. (Pubitemid 30626906)
42. Khorasani H, Zheng Z, Nguyen C, Zara J, Zhang XL, et al. (2011) A Quantitative Approach to Scar Analysis. American Journal of Pathology 178: 621-628.
43. Soo C, Beanes SR, Hu F-Y, Zhang X, Dang C, et al. (2003) Ontogenetic transition in fetal wound transforming growth factor- b regulation correlates with collagen organization. American Journal of Pathology 163: 2459-2476. (Pubitemid 37466487)
44. Allen A, Southern S (2002) A novel technique of computer-assisted image analysis to quantify molecular stress in cetaceans.
45. Denton CP, Khan K, Hoyles RK, Shiwen X, Leoni P, et al. (2009) Inducible lineage-specific deletion of TbetaRII in fibroblasts defines a pivotal regulatory role during adult skin wound healing. J Invest Dermatol 129: 194-204.
46. Xiao YQ, Liu K, Shen JF, Xu GT, Ye W (2009) SB-431542 inhibition of scar formation after filtration surgery and its potential mechanism. Invest Ophthalmol Vis Sci 50: 1698-1706.
47. Inman GJ, Nicolas FJ, Callahan JF, Harling JD, Gaster LM, et al. (2002) SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7. Mol Pharmacol 62: 65-74. (Pubitemid 34680517)
48. Yamanaka O, Yuan Y, Coulson-Thomas VJ, Gesteira TF, Call MK, et al. (2013) Lumican Binds ALK5 to Promote Epithelium Wound Healing. PLoS One 8: e82730.
49. Mariano J, Montuenga L, Prentice M, Cuttitta F, Jakowlew S (1998) Concurrent and distinct transcription and translation of transforming growth factor-β type I and type II receptors in rodent embryogenesis. Int J Dev Biol 42: 1125-1136. (Pubitemid 28561894)
50. Lopez-Casillas F, Cheifetz S, Doody J, Andres J, Lane W, et al. (1991) Structure and expression of the membrane proteoglycan betaglycan, a component of the TGF-beta receptor system. Cell 67: 785-795. (Pubitemid 121001491)
51. Stoff A, Rivera AA, Mathis JM, Moore ST, Banerjee NS, et al. (2007) Effect of adenoviral mediated overexpression of fibromodulin on human dermal fibroblasts and scar formation in full-thickness incisional wounds. J Mol Med 85: 481-496. (Pubitemid 46701657)
52. Honardoust D, Varkey M, Hori K, Ding J, Shankowsky HA, et al. (2011) Small leucine-rich proteoglycans, decorin and fibromodulin, are reduced in postburn hypertrophic scar. Wound Repair and Regeneration 19: 368-378.
53. Honardoust D, Varkey M, Marcoux Y, Shankowsky HA, Tredget EE (2012) Reduced Decorin, Fibromodulin, and Transforming Growth Factor-beta 3 in Deep Dermis Leads to Hypertrophic Scarring. Journal of Burn Care & Research 33: 218-227.
54. Brandes ME, Mai UE, Ohura K, Wahl SM (1991) Type I transforming growth factor-beta receptors on neutrophils mediate chemotaxis to transforming growth factor-beta. J Immunol 147: 1600-1606.
55. Brandes ME, Wakefield LM, Wahl SM (1991) Modulation of monocyte type I transforming growth factor-beta receptors by inflammatory stimuli. J Biol Chem 266: 19697-19703. (Pubitemid 21908283)
56. Lagraoui M, Gagnon L (1997) Enhancement of human neutrophil survival and activation by TGF-beta 1. Cell Mol Biol (Noisy-le-grand) 43: 313-318.
57. Wahl SM, Hunt DA, Wakefield LM, Mccartneyfrancis N, Wahl LM, et al. (1987) Transforming Growth-Factor Type-Beta Induces Monocyte Chemotaxis and Growth-Factor Production. Proc Natl Acad Sci U S A 84: 5788-5792. (Pubitemid 17130416)
58. Eming SA, Krieg T, Davidson JM (2007) Inflammation in wound repair: Molecular and cellular mechanisms. Journal of Investigative Dermatology 127: 514-525.
59. Hebda PA (1988) Stimulatory effects of transforming growth factor-beta and epidermal growth factor on epidermal cell outgrowth from porcine skin explant cultures. Journal of Investigative Dermatology 91: 440-445.
60. Sun T, Adra S, Smallwood R, Holcombe M, MacNeil S (2009) Exploring hypotheses of the actions of TGF-beta1 in epidermal wound healing using a 3D computational multiscale model of the human epidermis. PLoS One 4: e8515.
61. Decline F, Okamoto O, Mallein-Gerin F, Helbert B, Bernaud J, et al. (2003) Keratinocyte motility induced by TGF-beta1 is accompanied by dramatic changes in cellular interactions with laminin 5. Cell Motil Cytoskeleton 54: 64-80. (Pubitemid 36033839)
62. Cui W, Fowlis DJ, Cousins FM, Duffie E, Bryson S, et al. (1995) Concerted action of TGF-beta 1 and its type II receptor in control of epidermal homeostasis in transgenic mice. Genes Dev 9: 945-955.
63. Lopezcasillas F, Payne HM, Andres JL, Massague J (1994) Betaglycan Can Act as a Dual Modulator of Tgf-Beta Access to Signaling Receptors - Mapping of Ligand-Binding and Gag Attachment Sites. Journal of Cell Biology 124: 557-568. (Pubitemid 24064466)
64. Svensson L, Narlid I, Oldberg A (2000) Fibromodulin and lumican bind to the same region on collagen type I fibrils. FEBS Lett 470: 178-182. (Pubitemid 30151092)
65. Ezura Y, Chakravarti S, Oldberg A, Chervoneva I, Birk DE (2000) Differential expression of lumican and fibromodulin regulate collagen fibrillogenesis in developing mouse tendons. Journal of Cell Biology 151: 779-787.
66. Kalamajski S, Oldberg A (2009) Homologous Sequence in Lumican and Fibromodulin Leucine-rich Repeat 5-7 Competes for Collagen Binding. Journal Of Biological Chemistry 284: 534-539.
67. Niewiarowska J, Brezillon S, Sacewicz-Hofman I, Bednarek R, Maquart FX, et al. (2011) Lumican inhibits angiogenesis by interfering with alpha2beta1 receptor activity and downregulating MMP-14 expression. Thromb Res 128: 452-457.
68. Jian J, Zheng Z, Zhang K, Rackhon TM, Hsu C, et al. (2013) Fibromodulin promoted in vitro and in vivo angiogenesis. Biochemical and Biophysical Research Communication 436.
69. Martin P (1997) Wound healing - aiming for perfect skin regeneration. Science 276: 75-81.
70. Sjoberg A, Onnerfjord P, Morgelin M, Heinegard D, Blom AM (2005) The extracellular matrix and inflammation - Fibromodulin activates the classical pathway of complement by directly binding C1q. Journal of Biological Chemistry 280: 32301-32308. (Pubitemid 41361839)
71. Bossi F, Rizzi L, Bulla R, Tripodo C, Guarnotta C, et al. (2011) C1q induces in vivo angiogenesis and promotes wound healing. Molecular Immunology 48: 1676-1677.
72. Sinno H, Malholtra M, Lutfy J, Jardin B, Winocour S, et al. (2013) Topical application of complement C3 in collagen formulation increases early wound healing. Journal of Dermatological Treatment 24: 141-147.
73. Roberts AB, Sporn MB (1996) Transforming growth factor-beta. In: Clark RAF, editor. The Molecular and Cellular Biology of Wound Repair. New York: Plenum Press. pp. 275-308.
74. Ikushima H, Miyazono K (2012) TGF-beta signal transduction spreading to a wider field: a broad variety of mechanisms for context-dependent effects of TGF-beta. Cell Tissue Res 347: 37-49.
75. Leask A, Abraham DJ (2004) TGF-beta signaling and the fibrotic response. Faseb Journal 18: 816-827.
76. Massague J (2012) TGFbeta signalling in context. Nat Rev Mol Cell Biol 13: 616-630.
77. Beanes SR, Dang C, Soo C, Ting K (2003) Skin repair and scar formation: the central role of TGF-beta. Expert Rev Mol Med 5: 1-22.
78. Levine JH, Moses HL, Gold LI, Nanney LB (1993) Spatial and Temporal Patterns of Immunoreactive Transforming Growth-Factor-Beta-1, Beta-2, and Beta-3 during Excisional Wound Repair. American Journal of Pathology 143: 368-380. (Pubitemid 24058192)
79. Frank S, Madlener M, Werner S (1996) Transforming growth factors beta 1, beta 2, and beta 3 and their receptors are differentially regulated during normal and impaired wound healing. Journal of Biological Chemistry 271: 10188-10193. (Pubitemid 26131583)
80. Goldberg M, Septier D, Oldberg A, Young MF, Ameye LG (2006) Fibromodulin-deficient mice display impaired collagen fibrillogenesis in predentin as well as altered dentin mineralization and enamel formation. Journal of Histochemistry & Cytochemistry 54: 525-537.
81. Ranjzad P, Salem HK, Kingston PA (2009) Adenovirus-mediated gene transfer of fibromodulin inhibits neointimal hyperplasia in an organ culture model of human saphenous vein graft disease. Gene Ther 16: 1154-1162.
82. Oldberg A, Kalamajski S, Salnikov AV, Stuhr L, Morgelin M, et al. (2007) Collagen-binding proteoglycan fibromodulin can determine stroma matrix structure and fluid balance in experimental carcinoma. Proc Natl Acad Sci U S A 104: 13966-13971. (Pubitemid 350003321)
83. Mayr C, Bund D, Schlee M, Moosmann A, Kofler DM, et al. (2005) Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8(+) autologous T lymphocytes. Blood 105: 1566-1573. (Pubitemid 40223676)
84. Mikaelsson E, Danesh-Manesh AH, Luppert A, Jeddi-Tehrani M, Rezvany MR, et al. (2005) Fibromodulin, an extracellular matrix protein: characterization of its unique gene and protein expression in B-cell chronic lymphocytic leukemia and mantle cell lymphoma. Blood 105: 4828-4835. (Pubitemid 40807310)
85. Levens E, Luo XP, Ding L, Williams RS, Chegini N (2005) Fibromodulin is expressed in leiomyoma and myometrium and regulated by gonadotropinreleasing hormone analogue therapy and TGF-beta through Smad and MAPK-mediated signalling. Molecular Human Reproduction 11: 489-494. (Pubitemid 41258235)
86. Qian H, Xiao Y, Bartold PM (2004) Immunohistochemical localization and expression of fibromodulin in adult rat periodontium and inflamed human gingiva. Oral Diseases 10: 233-239. (Pubitemid 38868577)